Iterum Therapeutics plc Ordinary Share (ITRM) is a publicly traded Healthcare sector company. As of May 21, 2026, ITRM trades at $0.03 with a market cap of $1.60M and a P/E ratio of -0.04. ITRM moved -28.57% today. Year to date, ITRM is -94.99%; over the trailing twelve months it is -97.56%. Its 52-week range spans $0.03 to $3.02. Analyst consensus is hold with an average price target of $0.00. Rallies surfaces ITRM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns ITRM stock?
Hedge funds tracked by Rallies that own ITRM include Renaissance Technologies. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Iterum Therapeutics plc Ordinary Share.
ITRM Key Metrics
Key financial metrics for ITRM
Metric
Value
Price
$0.03
Market Cap
$1.60M
P/E Ratio
-0.04
EPS
$-0.72
Dividend Yield
0.00%
52-Week High
$3.02
52-Week Low
$0.03
Volume
65.74M
Avg Volume
0
Revenue (TTM)
$390.00K
Net Income
$-26.96M
Gross Margin
0.00%
Top Hedge Funds Holding ITRM
Renaissance Technologies holds 438.82K shares of ITRM, changed +585.41% as of Dec 31, 2024.
Hedge funds tracked by Rallies that own ITRM include Renaissance Technologies. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Iterum Therapeutics plc Ordinary Share.
Does Rallies show 13F holders for ITRM?
Yes. Rallies tracks hedge fund and 13F ownership data for ITRM, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ITRM research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ITRM. It does not provide personalized investment advice.
